High Affinity Fluorescent Probe for Proteinase-Activated Receptor 2 (PAR2)

被引:6
|
作者
LeSarge, Jordan C. [1 ]
Thibeault, Pierre [2 ]
Milne, Mark [5 ]
Ramachandran, Rithwik [2 ]
Luyt, Leonard G. [1 ,3 ,4 ,5 ]
机构
[1] Univ Western Ontario, Dept Chem, 1151 Richmond St, London, ON N6A 3K7, Canada
[2] Univ Western Ontario, Dept Physiol & Pharmacol, 1151 Richmond St, London, ON N6A 3K7, Canada
[3] Univ Western Ontario, Dept Oncol, 1151 Richmond St, London, ON N6A 3K7, Canada
[4] Univ Western Ontario, Dept Med Imaging, 1151 Richmond St, London, ON N6A 3K7, Canada
[5] Lawson Hlth Res Inst, London Reg Canc Program, 800 Commissioners Rd East, London, ON N6A 5W9, Canada
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2019年 / 10卷 / 07期
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
Proteinase-activated receptor 2 (PAR2); peptide; targeted fluorescent probes; fluorescence imaging; structure-activity relationship; MOLECULAR-CLONING; EXPRESSION; POTENT; BINDING; PROTEASE-ACTIVATED-RECEPTOR-1; 2-FUROYL-LIGRLO-AMIDE; AGONISTS; PEPTIDE; GROWTH; CANCER;
D O I
10.1021/acsmedchemlett.9b00094
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
PAR2 is a proteolytically activated G protein coupled receptor (GPCR) that is implicated in various cancers and inflammatory diseases. Ligands with low nano molar affinity for PAR2 have been developed, but there is a paucity of research on the development of PAR2-targeting imaging probes. Here, we report the development of seven novel PAR2-targeting compounds. Four of these compounds are highly potent and selective PAR2-targeting peptides (EC50 = 10 to 23 nM) that have a primary amine handle available for facile conjugation to various imaging components. We describe a peptide of the sequence Isox-Cha-Chg-ARK(Sulfo-Cy5)-NH2 as the most potent and highest affinity PAR2-selective fluorescent probe reported to date (EC50 = 16 nM, K-D = 38 nM). This compound has a greater than 10-fold increase in potency and binding affinity for PAR2 compared to the leading previously reported probe and is conjugated to a red-shifted fluorophore, enabling in vitro and in vivo studies.
引用
收藏
页码:1045 / 1050
页数:11
相关论文
共 50 条
  • [31] Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo
    Kanke, T.
    Kabeya, M.
    Kubo, S.
    Kondo, S.
    Yasuoka, K.
    Tagashira, J.
    Ishiwata, H.
    Saka, M.
    Furuyama, T.
    Nishiyama, T.
    Doi, T.
    Hattori, Y.
    Kawabata, A.
    Cunningham, M. R.
    Plevin, R.
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (01) : 361 - 371
  • [32] PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice
    Jones, Shannon M.
    Mann, Adrien
    Conrad, Kelsey
    Saum, Keith
    Hall, David E.
    McKinney, Lisa M.
    Robbins, Nathan
    Thompson, Joel
    Peairs, Abigail D.
    Camerer, Eric
    Rayner, Katey J.
    Tranter, Michael
    Mackman, Nigel
    Owens, A. Phillip, III
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (06) : 1271 - 1282
  • [33] Changes in Proteinase-Activated Receptor 2 Expression in the Human Tooth Pulp in Relation to Caries and Pain
    Morgan, Claire R.
    Rodd, Helen D.
    Clayton, Nick
    Boissonade, Fiona M.
    JOURNAL OF OROFACIAL PAIN, 2009, 23 (03): : 265 - 274
  • [34] PAR2: The Cornerstone of Pancreatic Diseases
    Suhaj, Petr
    Olejar, Tomas
    Matej, Radoslav
    PHYSIOLOGICAL RESEARCH, 2022, 71 (05) : 583 - 596
  • [35] Human osteoarthritis knee joint synovial fluids cleave and activate Proteinase-Activated Receptor (PAR) mediated signaling
    Chandrabalan, Arundhasa
    Firth, Andrew
    Litchfield, Robert B.
    Appleton, C. Thomas
    Getgood, Alan
    Ramachandran, Rithwik
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [36] A New Strategy in Modulating the Protease-Activated Receptor 2 (Par2) in Autoimmune Diseases
    Khoon, Lynn
    Piran, Ron
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (01)
  • [37] Proteinase-activated receptor-2 expression in basal and squamous cell carcinomas compared with normal skin
    Dastgheib, Ladan
    Monabati, Ahmad
    Mohammadian, Amanollah
    Sari-Aslani, Fatemeh
    Marzban, Saeed
    Namazi, Mohammad R.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2009, 36 (03) : 314 - 317
  • [38] Characterization of proteinase-activated receptor 2 signalling and expression in rat hippocampal neurons and astrocytes
    Bushell, Trevor J.
    Plevin, Robin
    Cobb, Stuart
    Irving, Andrew J.
    NEUROPHARMACOLOGY, 2006, 50 (06) : 714 - 725
  • [39] Proteinase-activated receptor-2 modulates human macrophage differentiation and effector function
    Steven, Rachael
    Crilly, Anne
    Lockhart, John C.
    Ferrell, William R.
    McInnes, Iain B.
    INNATE IMMUNITY, 2013, 19 (06) : 663 - 672
  • [40] Proteinase-Activated Receptor 1 (PAR1) Regulates Leukemic Stem Cell Functions
    Baeumer, Nicole
    Krause, Annika
    Koehler, Gabriele
    Lettermann, Stephanie
    Evers, Georg
    Hascher, Antje
    Baeumer, Sebastian
    Berdel, Wolfgang E.
    Mueller-Tidow, Carsten
    Tickenbrock, Lara
    PLOS ONE, 2014, 9 (04):